Both classes lower blood glucose, promote weight loss, and reduce cardiovascular risk, but SGLT2 inhibitors have stronger evidence for kidney and heart failure protection and are generally preferred in those conditions
Boucherat, O
13.2% of participants developed gastrointestinal events on tirzepatide, but overall, the participants experienced greater weight reduction
Keep them away from light: Light can degrade glutathione, so store the vials in their original packaging or a dark container
You take one tablet in the morning, at least 30 minutes before your first food, beverage, or other oral medication
Private insurance thresholds Private insurance coverage for GLP-1 weight loss medications varies enormously by carrier, plan type, and even specific employer group